What is CBSC's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CBSC?

P/E (TTM) is n/a and 52-week range is $0.02 to $0.06 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CBSC figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Where is Cardiac Biotech Solutions Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Las Vegas, Nevada, US, 112.6M shares outstanding, ISIN US12506E1038 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Cardiac Biotech Solutions Inc

$CBSC

Health Care · Pharmaceuticals

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

Cardiac Biotech Solutions, Inc. engages in the provision of products and services in the ambulatory non-invasive cardiac monitoring space. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2001-09-28. The Company, through its international subsidiaries, provides products and services in the ambulatory non-invasive cardiac monitoring space. Its electrocardiogram (EKG) devices, interactive cloud-based acquisition software, and smartphone apps for both iPhone operating system (iOS) and Android platforms, enhance patient compliance and provide improved compliance for patients at risk of abnormal heart rhythms, as well as more accurate information for physicians. Its advanced technology is designed to improve patient outcomes and streamline cardiac monitoring for healthcare providers. Its MyCardia AT cardiac event monitor helps physicians detect, identify, and diagnose potential cardiac arrhythmias in patients with intermittent transient symptoms closer to the time that they occur up to a 30-day monitoring period.

Website

cardiacbiotech.com/

IPO

2001-09-28

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)